Palliative Care News

The addition of lorazepam to haloperidol reduced symptoms of agitated delirium among individuals with advanced cancers, according to study findings.

Guidelines for cannabis and prescription opioid use in the management of cancer-associated pain should reflect changing patient attitudes toward these approaches, according to study findings.

Clinicians in acute or post-acute care settings may delay or avoid serious illness conversations with patients whose cancer prognoses are worsening out of deference to the patient’s oncologist, according to study findings.

Olanzapine reduced severe nausea more effectively than prochlorperazine for patients with refractory symptoms after chemotherapy, according to results of a randomized phase 3 trial.

A 20-minute mindful breathing session rapidly reduced pain intensity and anxiety among people with cancer, according to results of a randomized controlled study.

A multilevel care intervention increase advanced care planning versus clinician-level intervention alone for patients with genitourinary cancer, according to study results.

In 2018, at the height of the chimeric antigen receptor T-cell therapy revolution and in the heart of its implementation, Healio’s Cell Therapy Next staff went onsite to University of Pennsylvania’s newly minted center.

Incorporating palliative care into a hematology/oncology fellowship improve fellows’ knowledge and confidence providing these services, according to research presented at ASCO Annual Meeting.

CHICAGO — Individuals with advanced cancer who received a two-component medical cannabis oil reported improvement in cancer-related pain, results from a randomized study showed.